Peptidream Inc.

As of June 30, 2026, Peptidream Inc. carries a market capitalization of 136.86B, placing it among publicly traded companies globally. Its enterprise value stands at 128.94B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Peptidream Inc.'s next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, Peptidream Inc. has 128.57M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Peptidream Inc. maintains a current ratio of 4.15, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Peptidream Inc.'s stock has declined approximately 36.16% over the past 52 weeks. The 50-day moving average sits at 1,066.56, while the 200-day moving average is 1,206.08.

As of June 30, 2026, Peptidream Inc. holds 23.61B in cash and equivalents against 15.69B in total debt, resulting in a net debt position of -7.91B. Total book value stands at 48.56B, with working capital of 25.10B providing operational flexibility.

Peptidream Inc.'s most recent stock split took place on June 28, 2017 with a 1:2 split ratio.